Figure 6 | Scientific Reports

Figure 6

From: Construction of a highly efficient CRISPR/Cas9-mediated duck enteritis virus-based vaccine against H5N1 avian influenza virus and duck Tembusu virus infection

Figure 6

Peripheral blood T-lymphocyte proliferation assay. Ducks were vaccinated with PBS, 105 PFU of C-KCE or C-KCE-HA/PrM-E (n = 3 per group) subcutaneously. On the day of final immunization (day 14), duck peripheral blood lymphocytes were evaluated by MTT assay. Data are shown as the mean ± SD. Statistically significant differences (P < 0.01) are indicated by **(compared with C-KCE or PBS group). ConA, Concanavalin A.

Back to article page